Research has found that the recognition and uptake of apoptotic tumor cells by DCs depend on the binding of calreticulin on the apoptotic tumor cell surface to its receptor LRP1, which can activate tumor-specific CD8+ T cells (234). Here, LRP1 is linked to neoplasm.